Key areas of interest include circadian rhythms, neurological conditions, metabolic disorders, and oncology.
During IPC 2024, George Paraskevakos shared recent updates on market developments and an overview of the Biotic-related survey.
The findings of a recent study suggest that Desulfovibrio can drive cancer progression, paving the way for therapeutic approached that targeting the gut microbiota.
The authors advocate for further research on worm-microbiota interactions, suggesting that new animal models could help inform strategies for improving health during early life.
The findings of a recent study may help clinicians to select more targeted antimicrobials based on where on the body the surgery is taking place or which type of bacteria…
The findings uncover a link between vitamin D, the immune system and gut bacteria, and they suggest that vitamin D levels could be important for cancer immunity and the efficacy…
The findings of a recent study show that Q-net can accurately predict the long-term trajectories of gut microbes and identify patterns indicative of future cognitive deficits.
The findings of a recent study suggest that the infant gut microbiota begins to develop circadian rhythms soon after birth, with diet having minimal influence on these microbial patterns.
VOWST is the first and only orally administered microbiota-based therapeutic approved by the U.S. FDA for the prevention of recurrent Clostridioides difficile infection in adults.
The findings of a recent study reveal how gut bacteria modify immune molecules in ways that lead to the development of IgA nephropathy.
